成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook Chinese Germany Japanese Korean

武漢敬康恩生物醫(yī)藥科技有限公司 Company Information
Company Name:    Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel:    13720134139 +86 -0-15871494362
Email:    orders@jknbiochem.com
Nationality:    China
WebSite:    www.jknbiochem.com
Product List:    5821
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Product List
Daratumumab 945721-28-8
Solanezumab 955085-14-0
Vedolizumab 943609-66-3
Rovelizumab 339086-79-2
Vepalimomab 195158-85-1
Nerelimomab 162774-06-3
Nacolomab Tafenatox 150631-27-9
Rilotumumab 872514-65-3
Maslimomab 127757-92-0
Bectumomab 158318-63-9
Zolimomabaritox 141483-72-9
Minretumomab 195189-17-4
Glembatumumab 1020264-78-1
Benralizumab 1044511-01-4
Fezakinumab 1007106-86-6
Girentuximab 916138-87-9
Intetumumab 725735-28-4
Secukinumab 1229022-83-6
Mavrilimumab 1085337-57-0
Dalotuzumab 1005389-60-5
Rontalizumab 948570-30-7
Lebrikizumab 953400-68-5
Suvizumab 914257-21-9
Sifalimumab 1006877-41-3
Teprotumumab 1036734-93-6
Drozitumab 912628-39-8
Placulumab 945781-29-3
Tildrakizumab 1326244-10-3
Lodelcizumab 1355338-54-3
Concizumab 1312299-39-0
Ozanezumab 1310680-64-8
Pritoxaximab 1351470-16-0
Vorsetuzumab 1165740-62-4
Nesvacumab 1296818-77-3
Setoxaximab 1351470-17-1
Modotuximab 1310460-86-6
Pidilizumab 1036730-42-3
Pinatuzumab Vedotin 1313706-14-7
Simtuzumab 1318075-13-6
Dusigitumab 1204390-13-5
Seribantumab 1334296-12-6
Evolocumab 1256937-27-5
Perakizumab 1331830-76-2
Orticumab 1314241-10-5
Lirilumab 1000676-41-4
Lampalizumab 1278466-20-8
Futuximab 1310460-85-5
Clazakizumab 1236278-28-6
Enoticumab 1192578-27-0
Ligelizumab 1322627-61-1
Parsatuzumab 1312797-14-0
Imgatuzumab 959963-46-3
Ocaratuzumab 1169956-08-4
Fasinumab 1190239-42-9
Alirocumab 1245916-14-6
Duligotuzumab 1314238-96-4
Bimagrumab 1356922-05-8
Vatelizumab 1238217-55-4
Quilizumab 1228538-47-3
Romosozumab 909395-70-6
Caplacizumab 915810-67-2
Sirukumab 1194585-53-9
Actoxumab 1245634-25-6
Flanvotumab 1188277-05-5
Patritumab 1262787-83-6
Indatuximab Ravtansine 1238517-16-2
Solitomab 1005198-65-1
Pateclizumab 1202526-59-7
Tabalumab 1143503-67-6
Bezlotoxumab 1246264-45-8
Vesencumab 1205533-60-3
Ublituximab 1174014-05-1
Mogamulizumab 1159266-37-1
Radretumab 1253180-81-2
Roledumab 1174008-79-7
Atinumab 1226761-65-4
Enavatuzumab 1062149-33-0
Etrolizumab 1044758-60-2
Ponezumab 1178862-65-1
Crenezumab 1095207-05-8
Narnatumab 1188275-92-4
Blosozumab 1132758-87-2
Icrucumab 1024603-92-6
Tregalizumab 1207446-68-1
Namilumab 1206681-39-1
Urelumab 934823-49-1
Oxelumab 1186098-83-8
Enokizumab 909875-08-7
Samalizumab 1073059-33-2
Fulranumab 902141-80-4
Onartuzumab 1133766-06-9
Carlumab 915404-94-3
Ozoralizumab 1167985-17-2
Ficlatuzumab 1174900-84-5
Brodalumab 1174395-19-7
Ensituximab 1092658-06-4
Olaratumab 1024603-93-7
Foralumab 946415-64-1
Olokizumab 1007223-17-7
Itolizumab 1116433-11-4
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2007©  ChemicalBook. All rights reserved.